Smoker's requisite

Abstract

A smoker's requisite embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof. The substance is embodied in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.

1 . A smoker's requisite which includes a carrier and a substance which is a combination of one or more of the following:
 a tryptamine derivative;   a protein;   a steroid;   a statin;   a sulphonamide;   a substituted indole;   a substituted imidazole;   a metal-containing compound; and   an anti-depressants;   
     the substance being embodied in the carrier such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker. 
   
   
       2 . The smoker's requisite according to  claim 1  wherein the tryptamine derivative is selected from any one, or any combination of serotonin and melatonin. 
   
   
       3 . The smoker's requisite according to  claim 1  wherein the protein is selected from any one, or any combination of endostatin and angiostatin. 
   
   
       4 . The smoker's requisite according to  claim 1  wherein the steroid is a steroidal anti-inflammatory compound. 
   
   
       5 . The smoker's requisite according to  claim 1  wherein the statin selected from any one, or any combination of lovastatin, simvastatin and pravastatin. 
   
   
       6 . The smoker's requisite according to  claim 1  wherein the sulphonamide is nimesulide. 
   
   
       7 . The smoker's requisite according to  claim 1  wherein the substituted indole is Iodine (etodolac). 
   
   
       8 . The smoker's requisite according to  claim 1  wherein the substituted imidazole is dacarbazine. 
   
   
       9 . The smoker's requisite according to  claim 1  wherein the metal-containing compound is selected from any one, or any combination of cisplatin and selenium compounds. 
   
   
       10 . The smoker's requisite according to  claim 1  wherein the anti-depressant is selected from any one, or any combination of the following: monoamine oxidase inhibitors selected from the hydrazine derivatives, isocarboxazid, phenelzine, nialamide, iproniazid and mebanzine, and the non-hydrazine monoamine oxidase inhibitors selected from pargyline, the tricyclic anti-depressants dibenzazepine, the zocyclohepetene derivatives amitriptyline, butriptyline, desipramine, clomipramine, protriptyline, nortriptyline, opipramol, trimipramine iprindole, and the tetracyclics maprotiline and mianserin.